Jean F. Voltaire

Array ( [id] => 6228866 [patent_doc_number] => 20100183604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'PREVENTIVE/REMEDY FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/665631 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 46345 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183604.pdf [firstpage_image] =>[orig_patent_app_number] => 12665631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263847 [patent_doc_number] => 07569612 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-08-04 [patent_title] => 'Methods of use of fenofibric acid' [patent_app_type] => utility [patent_app_number] => 12/141377 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37691 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569612.pdf [firstpage_image] =>[orig_patent_app_number] => 12141377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663133 [patent_doc_number] => 20080254040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS OR ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/140661 [patent_app_country] => US [patent_app_date] => 2008-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17884 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254040.pdf [firstpage_image] =>[orig_patent_app_number] => 12140661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164745 [patent_doc_number] => 08173688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Thiazole compounds, and compositions and methods using same' [patent_app_type] => utility [patent_app_number] => 12/138603 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7106 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173688.pdf [firstpage_image] =>[orig_patent_app_number] => 12138603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453287 [patent_doc_number] => 20090069324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'CHEMICAL INHIBITORS OF BFL-1 AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 12/130735 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27399 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069324.pdf [firstpage_image] =>[orig_patent_app_number] => 12130735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710592 [patent_doc_number] => 20080299118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'FXR Agonists for the Treatment of Malignancies' [patent_app_type] => utility [patent_app_number] => 12/130221 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16551 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299118.pdf [firstpage_image] =>[orig_patent_app_number] => 12130221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445159 [patent_doc_number] => 07863324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Chroman-derived compounds for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/129338 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14912 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863324.pdf [firstpage_image] =>[orig_patent_app_number] => 12129338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10044388 [patent_doc_number] => 09084771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Methods and compositions for treating cancer' [patent_app_type] => utility [patent_app_number] => 12/600553 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 30 [patent_no_of_words] => 15371 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201197 [patent_doc_number] => 08188130 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-05-29 [patent_title] => 'Anti-cancer hydantoin compounds and methods' [patent_app_type] => utility [patent_app_number] => 12/120756 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5148 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188130.pdf [firstpage_image] =>[orig_patent_app_number] => 12120756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839476 [patent_doc_number] => 20080279961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'TELOMERE TARGETING AGENTS AS STEM CELLS DIRECTED TREATMENTS' [patent_app_type] => utility [patent_app_number] => 12/118394 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27260 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279961.pdf [firstpage_image] =>[orig_patent_app_number] => 12118394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839626 [patent_doc_number] => 20150031708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'MODULATORS OF CFTR' [patent_app_type] => utility [patent_app_number] => 12/117941 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61996 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12117941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249373 [patent_doc_number] => 20100137398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'USE OF HDAC INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL CANCERS' [patent_app_type] => utility [patent_app_number] => 12/594613 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6949 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137398.pdf [firstpage_image] =>[orig_patent_app_number] => 12594613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859012 [patent_doc_number] => 20080267862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'METHOD OF TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/111253 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8295 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267862.pdf [firstpage_image] =>[orig_patent_app_number] => 12111253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515811 [patent_doc_number] => 20120315218 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-12-13 [patent_title] => 'Toxicology and Cellular Effect of Manufactured Nanomaterials' [patent_app_type] => utility [patent_app_number] => 12/111026 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 38566 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12111026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515811 [patent_doc_number] => 20120315218 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-12-13 [patent_title] => 'Toxicology and Cellular Effect of Manufactured Nanomaterials' [patent_app_type] => utility [patent_app_number] => 12/111026 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 38566 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12111026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417019 [patent_doc_number] => 20090042906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'METHODS FOR TREATING CANCERS ASSOCIATED WITH CONSTITUTIVE EGFR SIGNALING' [patent_app_type] => utility [patent_app_number] => 12/110275 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13711 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042906.pdf [firstpage_image] =>[orig_patent_app_number] => 12110275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685413 [patent_doc_number] => 20100120728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Method of Treating Vitamin D Insufficiency and Deficiency' [patent_app_type] => utility [patent_app_number] => 12/597230 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9110 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120728.pdf [firstpage_image] =>[orig_patent_app_number] => 12597230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887746 [patent_doc_number] => 20080262078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 12/106355 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6985 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262078.pdf [firstpage_image] =>[orig_patent_app_number] => 12106355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338053 [patent_doc_number] => 20090054517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Phytoestrogens As Regulators Of Hedgehog Signaling And Methods Of Their Use In Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 12/106993 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7177 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054517.pdf [firstpage_image] =>[orig_patent_app_number] => 12106993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509239 [patent_doc_number] => 20090082446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Use of Hydroxyoleic acid and related compounds in the manufacture of drugs' [patent_app_type] => utility [patent_app_number] => 12/082938 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5780 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082446.pdf [firstpage_image] =>[orig_patent_app_number] => 12082938 [rel_patent_id] =>[rel_patent_doc_number] =>)